Development of new therapy for canine mammary cancer with recombinant measles virus.
Shoji K, Yoneda M, Fujiyuki T, Amagai Y, Tanaka A, Matsuda A, Ogihara K, Naya Y, Ikeda F, Matsuda H, Sato H, Kai C.
Shoji K, et al. Among authors: ogihara k.
Mol Ther Oncolytics. 2016 Jan 13;3:15022. doi: 10.1038/mto.2015.22. eCollection 2016.
Mol Ther Oncolytics. 2016.
PMID: 27119113
Free PMC article.